Search results for "Digestive System"

showing 10 items of 1747 documents

Incidence of new foci of hepatocellular carcinoma after radiofrequency ablation: role of multidetector CT

2012

Purpose. The authors sought to assess the incidence of new foci of hepatocellular carcinoma (HCC) using multidetector computed tomography (MDCT) in patients treated with radiofrequency ablation (RFA). Materials and methods. Two readers retrospectively reviewed by consensus the follow-up MDCT studies of 125 patients (88 men and 37 women; mean age 68 years) with 141 HCCs (size 1–5.2 cm; mean 2.2 cm) treated with RFA. MDCT follow-up was performed at 1 and 3 months and every 6–12 months thereafter. Reviewers assessed: (1) the presence of new HCC foci in the same liver segment or in a different segment; (2) complete or incomplete tumor ablation; (3) tumour progression. Results. A total of 113 ne…

Malemedicine.medical_specialtyCarcinoma HepatocellularRadiofrequency ablationMultidetector ctSettore MED/01 - Statistica Medicalaw.inventionLiver neoplasmslawMultidetector Computed TomographymedicineHumansRadiology Nuclear Medicine and imagingAgedRetrospective StudiesNeuroradiologyChi-Square Distributionmedicine.diagnostic_testbusiness.industryIncidenceIncidence (epidemiology)Radiofrequency ablation (RFA)UltrasoundInterventional radiologyGeneral MedicineMiddle AgedHCCSmedicine.diseasedigestive system diseasesTreatment OutcomeLiverHepatocellular carcinomaCatheter AblationDisease ProgressionRadiofrequency ablation (RFA); Liver; CT; Liver neoplasmsFemaleRadiologyNeoplasm Recurrence LocalSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessFollow-Up StudiesCTLa radiologia medica
researchProduct

The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center

2019

Aims. To analyze the main etiological factors and some clinical features of patients with hepatocellular carcinoma (HCC) at diagnosis and to compare them with those we described ten years ago. Materials and Methods. We compared two groups of patients with HCC, Group 1 consisting of 132 patients (82 M, 50 F) diagnosed in the 2003–2008 period and Group 2 including 119 patients (82 M, 37 F) diagnosed in the 2013–2018 period. For all patients, age, sex, viral markers, alcohol consumption, serum alpha-fetoprotein (AFP) levels, and the main liver function parameters were recorded. The diagnosis of HCC was based on AASLD, EASL guidelines. The staging was classified according to the “Barcelona Clin…

Malemedicine.medical_specialtyCarcinoma HepatocellularSettore MED/09 - Medicina InternaArticle SubjectSingle CenterGastroenterologyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesEpidemiology Hepatocellular carcinoma HCV HBV NASH0302 clinical medicineRisk FactorsInternal medicineEpidemiologyHumansMedicineStaging systemAgedNeoplasm StagingGeneral Immunology and Microbiologybusiness.industryLiver NeoplasmsRGeneral MedicineHepatitis Bmedicine.diseaseHepatitis Cdigestive system diseases030220 oncology & carcinogenesisHepatocellular carcinomaEtiologyMedicineViral MarkersFemale030211 gastroenterology & hepatologyalpha-FetoproteinsLiver functionbusinessLiver cancerResearch ArticleBioMed Research International
researchProduct

The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transpl…

2020

BACKGROUND There is a lack of data on the use of direct-acting antivirals (DAA) on the risk of death and tumoral recurrence in patients with hepatitis C virus (HCV) and hepatocellular carcinoma (HCC) listed for liver transplantation (LT). We aimed to assess the impact of antiviral treatment on mortality and HCC recurrence patients with HCC-HCV. METHODS This was a retrospective multicenter study of patients with HCC-HCV listed for LT from 2005 to 2015. Patients were divided according to the antiviral treatment received after HCC diagnosis: DAA, interferon (IFN), or no antiviral. Intention-to-treat overall survival and HCC recurrence incidence were compared by the Kaplan-Meier method. Multiva…

Malemedicine.medical_specialtyCarcinoma HepatocellularTime FactorsWaiting Listsmedicine.medical_treatment030230 surgeryLiver transplantationGastroenterologyAntiviral AgentsRisk Assessment03 medical and health sciences0302 clinical medicineInterquartile rangeRisk FactorsInternal medicineCarcinomamedicineHumansRisk factorRetrospective StudiesTransplantationbusiness.industryIncidence (epidemiology)Hazard ratioLiver NeoplasmsRetrospective cohort studyMiddle Agedmedicine.diseaseHepatitis Cdigestive system diseasesLiver TransplantationTreatment OutcomeHepatocellular carcinoma030211 gastroenterology & hepatologyFemaleNeoplasm Recurrence LocalbusinessTransplantation
researchProduct

Multiple intrahepatic pseudocysts in acute pancreatitis

2007

Liver pseudocysts are a very rare complication in acute pancreatitis with only a few cases previously described. The lack of experience and literature on this condition leads to difficulties in the differential diagnosis and management. We report herein a case of acute pancreatitis who developed multiple intrahepatic pseudocysts. After complete imaging evaluation, the diagnosis was still unclear and the patient was operated on. The presence of liver lesions in patients with acute pancreatitis should raise the possibility of intrahepatic pseudocysts.

Malemedicine.medical_specialtyCase ReportSeverity of Illness IndexGastroenterologyDiagnosis DifferentialInternal medicineSeverity of illnessmedicineHumansIn patientAgedmedicine.diagnostic_testCystsbusiness.industryLiver DiseasesGastroenterologyMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance Imagingdigestive system diseasesTreatment OutcomeTomography x ray computedPancreatitisAcute DiseasePancreatitisAcute pancreatitisDifferential diagnosisTomography X-Ray ComputedbusinessComplicationWorld Journal of Gastroenterology
researchProduct

Hepatocellular carcinoma in patients with autoimmune hepatitis.

2009

To evaluate and confirm the low incidence of hepatocellular carcinoma (HCC) in patients with autoimmune hepatitis (AIH). At present only very few cases of HCC in patients with AIH and definite exclusion of chronic viral hepatitis have been published, suggesting that HCC due to AIH is rare.In order to further investigate the incidence of HCC in patients with AIH, we reviewed our large cohort of 278 patients with AIH.Eighty-nine patients (32%) were diagnosed with liver cirrhosis, a preneoplastic condition for HCC. We studied a total of 431 patient years of cirrhosis in these patients, an average 4.8 years per patient. During this period none of the patients of our own study cohort developed H…

Malemedicine.medical_specialtyCirrhosisAsiaCarcinoma HepatocellularAutoimmune hepatitisGastroenterologyCohort StudiesHepatitis B Chronicimmune system diseasesInternal medicineMedicineHumansneoplasmsAfrica South of the SaharaAgedHepatitisbusiness.industryLiver Cirrhosis BiliaryDeveloped CountriesIncidenceLiver NeoplasmsGastroenterologyGeneral MedicineHepatitis CHepatitis BHepatitis C ChronicMiddle Agedmedicine.diseasedigestive system diseasesBrief ArticlesHepatitis AutoimmuneHepatocellular carcinomaFemaleHemochromatosisbusinessLiver cancerViral hepatitisWorld journal of gastroenterology
researchProduct

Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort

2021

Real-world evidence on the course of Hepatitis C Virus (HCV) chronic liver disease after Sustained Virologic Response (SVR) obtained with direct-acting antiviral drugs (DAAs) are still limited, and the effects on mortality remain unclear. We evaluated the post-treatment survival of 4307 patients in the RESIST-HCV cohort (mean age 66.3 ± 11.6 years, 56.9% males, 24.7% chronic hepatitis, 66.9% Child-Pugh A cirrhosis and 8.4% Child-Pugh B cirrhosis) treated with DAAs between March 2015 and December 2016 and followed for a median of 73 weeks (range 16–152). Proportional cause-specific hazard regression for competing risks was used to evaluate the survival and to assess the predictors of liver a…

Malemedicine.medical_specialtyCirrhosisHepatitis C virusChronic Hepatitis; Cirrhosis; Competing risks; Survival.Hepacivirusmedicine.disease_causeChronic liver diseasecompeting riskAntiviral AgentsGastroenterologysurvivalchronic hepatitiVirologyDiabetes mellitusInternal medicinemedicineHumanschronic hepatitis cirrhosis competing risks survivalAgedcompeting risksHepatologybusiness.industrycirrhosisHazard ratioAlbuminOriginal ArticlesHepatitis C ChronicMiddle Agedmedicine.diseaseHepatitis Cdigestive system diseasesInfectious DiseasesCardiovascular DiseasesCohortOriginal ArticleFemalechronic hepatitisbusinessKidney diseasecirrhosi
researchProduct

Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological …

2013

Background: Radio-frequency ablation (RFA) has been employed in the treatment of Barcelona Clinic Liver Cancer (BCLC) early stage hepatocellular carcinoma (HCC) as curative treatments. Aim: To assess the effectiveness and the safety of RFA in patients with early HCC and compensated cirrhosis. Methods: A cohort of 151 consecutive patients with early stage HCC (122 Child-Pugh class A and 29 class B patients) treated with RFA were enrolled. Clinical, laboratory and radiological follow-up data were collected from the time of first RFA. A single lesion was observed in 113/151 (74.8%), two lesions in 32/151 (21.2%), and three lesions in 6/151 (4%) of patients. Results: The overall survival rates …

Malemedicine.medical_specialtyCirrhosisPercutaneousCarcinoma HepatocellularClinical Research Designmedicine.medical_treatmentCancer Treatmentlcsh:MedicineCatheter ablationGastroenterology and HepatologyGastroenterologyCohort StudiesInternal medicineGastrointestinal CancersGastrointestinal TumorsmedicineHumansStage (cooking)lcsh:ScienceAgedMultidisciplinaryRadiotherapybusiness.industryLiver Diseaseslcsh:RLiver NeoplasmsCancers and NeoplasmsHepatocellular CarcinomaMiddle Agedmedicine.diseaseAblationFibrosisdigestive system diseasessurgical procedures operativeTreatment OutcomeCirrhosisOncologyRadiological weaponHepatocellular carcinomaCatheter AblationMedicineHepatocellular carcinoma survival RFAlcsh:QFemalebusinessLiver cancerResearch ArticlePloS one
researchProduct

When GLP-1 hits the liver: a novel approach for insulin resistance and NASH

2012

nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum ranging from simple steatosis to steatohepatitis (NASH), increasing fibrosis and eventually, cirrhosis ([22][1]). Importantly, NASH accompanied by fibrosis and severe inflammation is the most relevant predictor for disease progression

Malemedicine.medical_specialtyCirrhosisPhysiologydigestive systemGastroenterologyGlucagon-Like Peptide-1 ReceptorSimple steatosisInsulin resistanceNon-alcoholic Fatty Liver DiseaseFibrosisPhysiology (medical)Internal medicineNonalcoholic fatty liver diseaseReceptors GlucagonAnimalsMedicineHepatologybusiness.industryDisease progressionGastroenterologynutritional and metabolic diseasesmedicine.diseasedigestive system diseasesSevere inflammationFatty LiverSteatohepatitisPeptidesbusinessAmerican Journal of Physiology-Gastrointestinal and Liver Physiology
researchProduct

Intraoperative Monitoring of Bladder and Internal Anal Sphincter Innervation: A Predictor of Erectile Function following Low Anterior Rectal Resectio…

2013

<b><i>Background:</i></b> The objective was to investigate whether two-dimensional intraoperative neuromonitoring (IONM) of pelvic autonomic nerves has the potential to predict erectile function (EF) following surgery for rectal cancer. <b><i>Methods:</i></b> A consecutive series of 17 sexually active male rectal cancer patients undergoing IONM-based nerve-sparing low anterior rectal resection were evaluated prospectively. IONM was performed by electric stimulation of the pelvic splanchnic nerves with concomitant electromyography of the internal anal sphincter and cystomanometry. Sexual function was assessed using a validated questionnaire. &l…

Malemedicine.medical_specialtyColorectal cancerUrinary BladderAnal CanalInternal anal sphincterErectile DysfunctionMonitoring IntraoperativemedicineHumansAutonomic PathwaysRectal resectionProspective StudiesProspective cohort studyDigestive System Surgical ProceduresAgedUrinary bladderRectal Neoplasmsbusiness.industryGastroenterologyAutonomic PathwaysMiddle AgedAnal canalmedicine.diseaseSurgerymedicine.anatomical_structureErectile dysfunctionSurgerybusinessOrgan Sparing TreatmentsFollow-Up StudiesDigestive Surgery
researchProduct

Neurotensin: dual effect on the motor activity of rat duodenum

1992

The effects of neurotensin on mechanical activity of rat duodenum were investigated using an isometric-isovolumic preparation. Neurotensin (1 pM to 10 nM) induced a concentration-dependent, tetrodotoxin (TTX)-insensitive fall in both endoluminal pressure and isometric tension. At higher concentrations of neurotensin (1 nM to 1 microM) the relaxation was followed by a concentration-dependent TTX-insensitive contraction, detected only by an increase in endoluminal pressure. Different concentrations of neurotensin were required to desensitize the relaxant and the contractile actions of the neuropeptide. The relaxation was antagonized by apamin, while the contractile response was blocked by nif…

Malemedicine.medical_specialtyContraction (grammar)NifedipineDuodenumMuscle RelaxationNeuropeptideIn Vitro TechniquesBiologyApamincomplex mixturesdigestive systemchemistry.chemical_compoundNifedipineInternal medicinemedicineAnimalsReceptors NeurotensinNeurotensinPharmacologymusculoskeletal neural and ocular physiologydigestive oral and skin physiologyRats Inbred StrainsElectric StimulationRatsReceptors NeurotransmitterMuscle relaxationEndocrinologyApaminnervous systemchemistryTetrodotoxinCalciummedicine.symptomGastrointestinal MotilityMuscle ContractionNeurotensinmedicine.drugMuscle contractionEuropean Journal of Pharmacology
researchProduct